Tu2042 CHILDREN AND ADOLESCENTS WITH DISORDERS OF GUT-BRAIN INTERACTION AND COMORBID HYPERMOBILITY AS WELL AS ORTHOSTATIC SYMPTOMS EXPERIENCE SEVERE DEPRESSION, NAUSEA, SOMATIZATION, AND DISABILITY Read More →
527 BEYOND CALORIES FOR DIETARY MANAGEMENT IN MAFLD: EMERGING EVIDENCE FOR DIET MODULATION VIA THE GUT-LIVER-AXIS Read More →
Tu1916 LABTHERA-002, A LIVE BIOTHERAPEUTIC PRODUCT, IMPROVES THE FOLFOX-INDUCED CACHEXIA IN COLORECTAL CANCER MICE MODEL THROUGH GUT MICROBIOTA MODULATION. Read More →
Tu2046 ACUTE GASTROENTERITIS IS A RISK FACTOR FOR THE DEVELOPMENT OF DISORDERS OF GUT-BRAIN INTERACTIONS IN CHILDREN Read More →
Mo1928 THE ROLE OF GUT MICROBIOTA AND INNATE IMMUNE RESPONSE IN AN AUTOIMMUNE PANCREATITIS MODEL Read More →
Mo1898 DAILY SUPPLEMENTATION WITH A MULTI-SPECIES SYNBIOTIC (DS-01) DURING AND AFTER ANTIBIOTIC TREATMENT PROTECTS AGAINST THE LOSS OF LOW-ABUNDANCE BACTERIAL SPECIES WHILE ENHANCING GUT BARRIER INTEGRITY Read More →
Mo1561 GUT SELECTIVE BIOLOGIC, VEDOLIZUMAB, IS ASSOCIATED WITH LOWER RATES OF LIVER RELATED COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH CIRRHOSIS-A NATIONWIDE ANALYSIS Read More →
Tu1900 PROSPECTIVE STUDY OF GASTROINTESTINAL PATHOGENS IN FLARES OF INFLAMMATORY BOWEL DISEASE: CLOSTRIDIOIDES DIFFICILE IMPACTS GUT MICROBIOME RECOVERY AND OUTCOMES Read More →
Tu1897 ASSOCIATION OF ANTI-GRANULOCYTE-MACROPHAGE COLONYSTIMULATING FACTOR ANTIBODIES WITH THE RISK OF CROHN'S DISEASE ONSET AND INTERACTION WITH GUT MICROBIOTA Read More →
Tu1166 IMPACT OF ECONOMIC AND PSYCHOSOCIAL FACTORS ON SYMPTOM SEVERITY IN PATIENTS WITH DISORDERS OF GUT-BRAIN INTERACTION DURING THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW AND META-ANALYSIS Read More →
Tu1684 REVISITING THE SUBTYPING OF LOWER GASTROINTESTINAL DISORDERS OF GUT-BRAIN INTERACTION PATIENTS USING UNSUPERVISED MACHINE LEARNING Read More →
179 MACROPHAGE-INDUCED ENTERIC NEURODEGENERATION LEADS TO SYNAPTIC DAMAGE AND MOTILITY IMPAIRMENT DURING POSTOPERATIVE GUT INFLAMMATION Read More →
181 INTRINSIC PRIMARY AFFERENT NEURONS REGULATE INTESTINAL CGRP LEVELS THROUGH A NOVEL, GUT-SPECIFIC AUTOCRINE PATHWAY Read More →
